News FDA Panel Thumbs Up for Teprotumumab for Thyroid Eye Disease by Medscape • 2019/12/16 • 0 Comments FDA panel unanimously recommends approval of teprotumumab for the treatment of active thyroid eye disease. 'I think we're finally going to be able to get a lot of people some help,' said one member. Medscape Medical News Full Story →